Figure 3. Differences in expression levels of 5 predicted mRNAs in primary brain tissues of AD patients. (A) ITGB8, (B) GJA1, (C) DTNA, (D) NRXN1, and (E) GUCY1A2 expression in Entorhinal Cortex, Hippocampus, Temporal Cortex, Frontal Cortex.